These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36320433)

  • 21. Targeting
    Kalera K; Liu R; Lim J; Pathirage R; Swanson DH; Johnson UG; Stothard AI; Lee JJ; Poston AW; Woodruff PJ; Ronning DR; Eoh H; Swarts BM
    ACS Infect Dis; 2024 Apr; 10(4):1391-1404. PubMed ID: 38485491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular biology of mycobacterial trehalose in the quest for advanced tuberculosis therapies.
    Nobre A; Alarico S; Maranha A; Mendes V; Empadinhas N
    Microbiology (Reading); 2014 Aug; 160(Pt 8):1547-1570. PubMed ID: 24858083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis.
    Urban M; Šlachtová V; Brulíková L
    Eur J Med Chem; 2021 Feb; 212():113139. PubMed ID: 33422979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azide-Masked Fluorescence Turn-On Probe for Imaging Mycobacteria.
    Liyanage SH; Raviranga NGH; Ryan JG; Shell SS; Ramström O; Kalscheuer R; Yan M
    JACS Au; 2023 Apr; 3(4):1017-1028. PubMed ID: 37124305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
    Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
    Front Immunol; 2014; 5():180. PubMed ID: 24795723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
    Park HE; Lee W; Shin MK; Shin SJ
    Front Immunol; 2021; 12():703060. PubMed ID: 34262571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent updates on drug resistance in Mycobacterium tuberculosis.
    Singh R; Dwivedi SP; Gaharwar US; Meena R; Rajamani P; Prasad T
    J Appl Microbiol; 2020 Jun; 128(6):1547-1567. PubMed ID: 31595643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates.
    Low JL; Wu ML; Aziz DB; Laleu B; Dick T
    Front Microbiol; 2017; 8():1539. PubMed ID: 28861054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of potential Mycolyltransferase Ag85C inhibitors of Mycobacterium tuberculosis H37Rv via Virtual High Throughput Screening and Binding free energy studies.
    Pant R; Joshi A; Maiti P; Nand M; Pande V; Chandra S
    J Mol Graph Model; 2020 Jul; 98():107584. PubMed ID: 32200279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
    Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS
    Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-mycobacterial Activity of 22 Iranian Endemic or Rare Plant Extracts Against Multi-drug and Extensively Drug-resistant
    Dehestani S; Davoodi J; Emami SA; Seddighinia FS; Sahebkar A; Soleimanpour S
    Comb Chem High Throughput Screen; 2022; 25(5):870-876. PubMed ID: 33588723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamins Based Novel Target Pathways/Molecules as Possible Emerging Drug Targets for the Management of Tuberculosis.
    Sharma A; Jain K; Flora SJS
    Med Chem; 2018; 14(3):212-224. PubMed ID: 29110620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium tuberculosis Rv1324 Protein Contributes to Mycobacterial Persistence and Causes Pathological Lung Injury in Mice by Inducing Ferroptosis.
    Shi X; Li C; Cheng L; Ullah H; Sha S; Kang J; Ma X; Ma Y
    Microbiol Spectr; 2023 Feb; 11(1):e0252622. PubMed ID: 36625672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allicin enhances antimicrobial activity of macrophages during Mycobacterium tuberculosis infection.
    Dwivedi VP; Bhattacharya D; Singh M; Bhaskar A; Kumar S; Fatima S; Sobia P; Kaer LV; Das G
    J Ethnopharmacol; 2019 Oct; 243():111634. PubMed ID: 30537531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology.
    Chandra P; Rajmani RS; Verma G; Bhavesh NS; Kumar D
    mSphere; 2016; 1(2):. PubMed ID: 27303736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent anti-mycobacterial and immunomodulatory activity of some bioactive molecules of Indian ethnomedicinal plants that have the potential to enter in TB management.
    Sarangi A; Das BS; Patnaik G; Sarkar S; Debnath M; Mohan M; Bhattacharya D
    J Appl Microbiol; 2021 Oct; 131(4):1578-1599. PubMed ID: 33772980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alginate-Capped Silver Nanoparticles as a Potent Anti-mycobacterial Agent Against
    Chen CC; Chen YY; Yeh CC; Hsu CW; Yu SJ; Hsu CH; Wei TC; Ho SN; Tsai PC; Song YD; Yen HJ; Chen XA; Young JJ; Chuang CC; Dou HY
    Front Pharmacol; 2021; 12():746496. PubMed ID: 34899300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.